17-HYDROXYPROGESTERONE (17-OHP) - ANVISA Registration 80103990074

Access comprehensive regulatory information for 17-HYDROXYPROGESTERONE (17-OHP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80103990074 and manufactured by RADIM SPA. The registration is held by RADIM LATINO AMERICA DIAGNOSTICO LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIAMETRA SRL, DRG INSTRUMENTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80103990074
Registration Details
ANVISA Registration Number: 80103990074
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

17-ALFA-HIDROXIPROGESTERONA
Risk Class II

Registration Details

80103990074

25351065489200791

04595434000132

Company Information

RADIM SPA
Italy
PT: ITÁLIA

Dates and Status

May 14, 2007

VIGENTE

09/18/2025 19:00:01